Bioactive Compounds
-
B5378 Conantokin-TSummary: Non-competitive NMDA receptor antagonist -
B5476 Hemopressin (human, mouse)Summary: CB1 receptor inverse agonist; endogenous peptide substrate for endopeptidase 24.15 (ep24.15), neurolysin (ep24.16) and ACE -
B5699 P11Summary: antagonist of the integrin αvβ3-vitronectin interaction -
A4137 AZD1480Target: JAKSummary: JAK2 inhibitor,ATP-competitive and novel -
A4164 AZD2461Target: PARPSummary: Novel PARP inhibitor -
A4032 VX-222 (VCH-222, Lomibuvir)Target: HCV polymeraseSummary: NNI of HCV RNA polymerase -
A4096 Belinostat (PXD101)2 CitationTarget: Histone Deacetylases (HDACs)Summary: Hydroxamate-type HDAC inhibitor -
A8201 Amprenavir (agenerase)Summary: HIV-1 protease inhibitor -
A4120 MK-5108 (VX-689)Summary: Aurora-A kinase inhibitor,highly selective -
A4010 Salinosporamide A (NPI-0052, Marizomib)Target: ProteasomeSummary: 20S proteasome inhibitor

